Article Sidebar

Download
PDF (Français)

Main Article Content

Abstract

Objective. Cervical cancer is likely to be the cancer that Cervico-Vaginal Smear (CVS) screening would be most contributive if performed under favorable conditions. In Cameroon, there is no quality control in the laboratories of Anatomy Cytology Pathology (ACP) and even less, there is no study on the quality of CVS sampling since its implementation in our country. However, in the laboratory, the quality of the sample determines the quality of the analysis and consequently the quality of the result and therapeutic orientations. The objective of our study was to evaluate the quality approach in the practice of CVS at the Gyneco-Obstetrics and Pediatric Hospital of Douala (GOPEHD). Material and methods. We have retrospectively conducted a descriptive study for a period from September 2015 to December 2016 where we performed a quality control of CVS at the sampling level. We have used the Bethesda System 2004 as a reference quality manual for evaluation. Results. In total of 508 CVS performed in clinical practice were reviewed and at the end of analyzes, we obtained 28.94% CVS satisfactory for the evaluation, 43.31% CVS satisfactory but limited by… and inadequate CVS rate was 27.76%. The analysis of the reports revealed that 65.31% of the CVS had no information regarding the quality of the sample. Conclusion. The quality of samples taken at GOPEHD is partially in line with Bethesda's recommendations, which implies that ACP professionals must truly engage in a process of improving quality in the practice of CVS.

Keywords

cervical cancer cervico-vaginal smear Quality Screening cervical cancer cervico-vaginal smear Quality Screening

Article Details

How to Cite
Demanou, G., Ateba, G.-R., Mbo Amvene, J., Adamo, B., Talom, A., Messah, S., Ferrand, J., & Colizzi, V. (2019). Evaluation of the Quality of Cervico-Vaginal Smears at Gyneco-Obstetric and Pediatric Hospital of Douala. HEALTH SCIENCES AND DISEASE, 20(3). https://doi.org/10.5281/hsd.v20i3.1401
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Sando Z, Fouogue JT, Fouelifack FY, Fouedjio JH, Mboudou ET, Essame JLO. Profil des cancers gynécologiques et mammaires à Yaoundé-Cameroun. Pan African Medical Journal. 2014;17(1).
  2. Ndoua CN, Tebeu PM, Kemfang JD, Kasia JM. Evaluation des résultats après traitement des lésions intra-épithéliales du col utérin par la cryothérapie: étude préliminaire au Centre Hospitalier Universitaire de Yaoundé: A propos de 21 cas. Pan African Medical Journal. 2015;20(1):2.
  3. Blanc B. Le dépistage du cancer du col de l'utérus. France: Springer Science & Business Media; 2005.
  4. Okonofua F. Prévention et contrôle du cancer du col en Afrique: Appel à l'action. African Journal of Reproductive Health. 2017;19(1).
  5. Bouassa RM, Prazuck T, Lethu T, Meye J, Bélec L. Cancer du col de l’utérus en Afrique subsaharienne: une maladie associée aux papillomavirus humains oncogènes, émergente et évitable. Médecine et Santé Tropicales. 2017;27(1):16-22.
  6. Duport N. Données épidémiologiques sur le cancer du col de l'utérus, État des connaissances. 2008 2008. In: Maladies chroniques et traumatismes [Internet]. France: Institut de Veille Sanitaire (IVS); [5 ; 11 ; 3 ; 4 et 9]. Available from: www.invs.sante.fr.
  7. OMS. Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. Organisation Mondiale de la Santé (OMS), 2013.
  8. ASC. Bethesda System for reporting Cervical Cytology 2014 : Online Atlas the University of Wisconsin System: AMERICAN SOCIETY OF CYTOPATHOLOGY; 2014 [updated September 08, 2015; cited 2017 June]. Available from: https://bethesda.soc.wisc.edu/.
  9. Auger M, Boerner S, Colgan T, Duggan M, Geldenhuys L, MacDonald L, et al. Directives concernant la pratique et l'assurance qualité en cytopathologie. Canada: Société Canadienne de Cytologie (SCC); 2005.
  10. Monsonégo J, Autillo-Touati A, Bergeron C, Dachez R, Liaras J, Saurel J, et al. Cytologie en phase liquide dans le cadre du dépistage primaire du cancer du col utérin: une étude multi-centrique. Gynécologie obstétrique & fertilité. 2001;29(11):799-807.
  11. Chosia M, Domagala W. Signification de l'évaluation de la qualité des frottis selon le système de Bethesda. Revue Francaise des Laboratoires. 2003;2003(356):27-30.
  12. Davey D, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Archives of pathology & laboratory medicine. 2000;124(2):203-11.

Most read articles by the same author(s)